Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Caveolin-3 (CAV3) is a muscle-specific protein crucial for forming caveolae, which are vital sarcolemmal invaginations.
• CAV3 monomers oligomerize to create scaffolding on the cytoplasmic side of the muscle cell membrane.

Purpose of the Study:

• To review reported cases of patients with caveolin-3 mutations.
• To detail the muscle disease phenotypes associated with specific caveolin-3 mutations.
• To examine the genotype-to-phenotype relationship in caveolin-3-related muscle disorders.

Main Methods:

• Review of existing literature on caveolin-3 mutations and associated muscle diseases.
• Analysis of patient case reports detailing genetic mutations and clinical phenotypes.
• Examination of the molecular mechanisms underlying aberrant caveolin-3 function.

Main Results:

• Eight autosomal dominant caveolin-3 mutations have been identified in humans.
• These mutations lead to aberrant caveolin-3 protein products that interfere with normal protein localization and function.
• Cellular defects include T-tubule derangement, sarcolemmal alterations, and subsarcolemmal vesicle formation.
• Caveolin-3 mutations are associated with four distinct muscle disease phenotypes: limb girdle muscular dystrophy, rippling muscle disease, distal myopathy, and hyperCKemia.

Conclusions:

• Caveolin-3 mutations provide a clear example of how genetic background influences phenotypic outcomes in muscle diseases.
• Understanding the molecular basis of these mutations is key to diagnosing and potentially treating associated muscular dystrophies.
• Further research into caveolin-3's role in muscle health can elucidate mechanisms of various myopathies.